About us
About Redenlab
Management team
Advisory board
Partners
What we do
Indications
Ataxia
Huntington’s Disease (HD)
Parkinson’s Disease
Our technology
News & Publications
News
Events
Publications
Employment opportunities
Clinical Trial Solutions
Virtual trials
Redenlab’s recording solutions
Protocol design and development
Data analysis and interpretation
Quality control and assurance
Project management
Contact Us
Suite 669, 585 Little Collins Street
Melbourne VIC 3000 Australia
info@redenlab.com
Linkedin
About us
About Redenlab
Management team
Advisory board
Partners
What we do
Indications
Ataxia
Huntington’s Disease (HD)
Parkinson’s Disease
Our technology
News & Publications
News
Events
Publications
Employment opportunities
Clinical Trial Solutions
Virtual trials
Redenlab’s recording solutions
Protocol design and development
Data analysis and interpretation
Quality control and assurance
Project management
Contact Us
multiple sclerosis
SCIENCE: What speech can tell us: A systematic review of dysarthria characteristics in multiple sclerosis
IMPORTANCE: Multiple sclerosis produces neurological impairments that are variable in duration, severity and quality. Speech is frequently impaired, resulting in...
Read more
×
×